BioSpace News Archive

IntelGenx Submits Montelukast VersaFilm Clinical Trial Application With Health Canada

IntelGenx announced that it has submitted a clinical trial application (“CTA”) to Health Canada for approval to initiate its Phase 2a proof of concept (“POC”) study with Montelukast in mild to moderate Alzheimer’s Disease (“AD”).

November 9, 2017

·

4 min read

Business

ContraFect Announces Third Quarter 2017 Financial Results

This quarter, ContraFect completed a public stock offering raising net proceeds of $37.1 million.

November 9, 2017

·

10 min read

Business

Ossur Hf: Management Changes

Kim de Roy has been appointed EVP of R&D and will become a member of Össur’s Executive Management.

November 9, 2017

·

1 min read

Business

Pulmatrix Provides Q3 2017 Highlights and Q3 2017 Updated Financials

Vectura and/or its partners will be responsible for all future development costs to advance the product for the U.S. Pulmatrix will provide the data package for PUR0200 and assist with the transfer of development and manufacturing activities to Vectura.

November 9, 2017

·

14 min read

Policy

New SAFE-BioPharma Standard Trust List Enables Validation of Digital Signatures in Both US and EU

A newly published SAFE-BioPharma Trust List vastly improves workflows involving sensitive and proprietary electronic documents exchanged between the US and the EU.

November 9, 2017

·

1 min read

Business

Qu Biologics Recruits Ms. Jennifer Archibald, Chief Financial Officer, and Mr. Alun Rees, VP, Manufacturing, to Leadership Team

Ms. Jennifer Archibald has joined Qu Biologics in the role of Chief Financial Officer (CFO) to head up the company’s financial and accounting operations.

November 9, 2017

·

5 min read

Business

Adamas Announces New Employment Inducement Grant - Nov. 9, 2017

The company’s board of directors granted five new employees the option to purchase an aggregate of 15,300 shares of the company’s common stock, at a per share exercise price of $27.00.

November 9, 2017

·

1 min read

Business

Crown Bioscience Announcing the 2017 Board of Directors Election Results

Dr. Guoliang Yu re-elected as the Chairman.

November 9, 2017

·

2 min read

Business

INC Research/inVentiv Health Reports Third Quarter 2017 Results

Net service revenue of $592.2 million and $1,102.4 million for the three and nine months ended September 30, 2017, respectively.

November 9, 2017

·

31 min read

Deals

Telix Pharmaceuticals Limited Successfully Completes $50M Oversubscribed Initial Public Offering

The IPO was strongly supported by institutional investors internationally and domestically, as well as by retail investors in Australia.

November 9, 2017

·

2 min read